Gold-based cancer therapy could face competition from other substances

The gold complex auranofin has traditionally been used for treating rheumatism but is also being evaluated as a treatment for certain forms of cancer. Researchers now show that other molecules that inhibit the same biological system have a more specific effect than auranofin and therefore may have greater potential as cancer therapies.

Source: sciencedaily.com

Related posts

Better medical record-keeping needed to fight antibiotic overuse

Global life expectancy to increase by nearly 5 years by 2050 despite geopolitical, metabolic, and environmental threats

Modern plant enzyme partners with surprisingly ancient protein